Pre-registration is not required.

LEARNING OBJECTIVES

As a result of participating in this activity, the learner will be able to:

• Understand the clinical and biologic features of neurotoxicity associated with chimeric antigen receptor T cell therapy
• Understand the clinical and biologic features of neurotoxicity associated with immune checkpoint inhibitors
• Explore the latest developments in the management of immunotherapy associated neurotoxicity

TARGETED AUDIENCE

Surgical, Medical and Radiation Oncology, Attending’s, Residents, Fellows, Faculty, ARNPs, RNs, PAs, and other Professional Staff.

ACCREDITATION

USF Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. USF Health designates this live activity for a maximum of 1 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.